Peel Hunt Initiates Coverage on Horizon Discovery Group (HZD)
Investment analysts at Peel Hunt initiated coverage on shares of Horizon Discovery Group (LON:HZD) in a research report issued to clients and investors on Tuesday. The firm set a “hold” rating and a GBX 181 ($2.50) price target on the stock. Peel Hunt’s target price would suggest a potential upside of 4.32% from the stock’s previous close.
Other equities analysts have also issued research reports about the company. Numis Securities reaffirmed a “buy” rating and issued a GBX 300 ($4.14) price objective on shares of Horizon Discovery Group in a research note on Friday, December 29th. N+1 Singer dropped their price objective on Horizon Discovery Group from GBX 250 ($3.45) to GBX 230 ($3.18) and set a “buy” rating for the company in a research note on Monday, February 19th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company has an average rating of “Buy” and an average target price of GBX 226.83 ($3.13).
Horizon Discovery Group (LON:HZD) opened at GBX 173.50 ($2.40) on Tuesday. The company has a market capitalization of $256.44 and a PE ratio of -1,239.29. Horizon Discovery Group has a 12 month low of GBX 160 ($2.21) and a 12 month high of GBX 294 ($4.06).
ILLEGAL ACTIVITY WARNING: “Peel Hunt Initiates Coverage on Horizon Discovery Group (HZD)” was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.watchlistnews.com/peel-hunt-initiates-coverage-on-horizon-discovery-group-hzd/1954929.html.
About Horizon Discovery Group
Horizon Discovery Group plc is a United Kingdom-based life science company. The Company uses gene editing and gene modulation application. Through the application of these technologies the Company enables researchers to alter almost any gene or modulate its function in human or mammalian cells to generate models that mimic the genetic abnormalities found in diseases such as cancer.
Receive News & Ratings for Horizon Discovery Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Discovery Group and related companies with MarketBeat.com's FREE daily email newsletter.